CN103319486B - 合成4H‑咪唑并[1,5‑a][1,4]苯二氮卓,特别是咪达唑仑的方法 - Google Patents
合成4H‑咪唑并[1,5‑a][1,4]苯二氮卓,特别是咪达唑仑的方法 Download PDFInfo
- Publication number
- CN103319486B CN103319486B CN201210076814.4A CN201210076814A CN103319486B CN 103319486 B CN103319486 B CN 103319486B CN 201210076814 A CN201210076814 A CN 201210076814A CN 103319486 B CN103319486 B CN 103319486B
- Authority
- CN
- China
- Prior art keywords
- midazolam
- benzodiazepine
- imidazos
- formula
- nitrae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 9
- DDLIGBOFAVUZHB-UHFFFAOYSA-N midazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F DDLIGBOFAVUZHB-UHFFFAOYSA-N 0.000 title abstract description 20
- 229960003793 midazolam Drugs 0.000 title abstract description 18
- GUJAGMICFDYKNR-UHFFFAOYSA-N 1,4-benzodiazepine Chemical compound N1C=CN=CC2=CC=CC=C12 GUJAGMICFDYKNR-UHFFFAOYSA-N 0.000 title description 2
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- 229940049706 benzodiazepine Drugs 0.000 claims abstract description 10
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000003054 catalyst Substances 0.000 claims abstract description 4
- 239000002904 solvent Substances 0.000 claims abstract description 4
- 238000006114 decarboxylation reaction Methods 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000006317 isomerization reaction Methods 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 238000012805 post-processing Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000003851 azoles Chemical class 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- CHCISLOJADQUNQ-UHFFFAOYSA-N climazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1Cl CHCISLOJADQUNQ-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- GPOKFLSWUBGZBM-UHFFFAOYSA-N 1,2-benzodiazepine-2-carboxylic acid Chemical class OC(=O)N1C=CC=C2C=CC=CC2=N1 GPOKFLSWUBGZBM-UHFFFAOYSA-N 0.000 description 1
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- SNNAXVYUFKNABL-UHFFFAOYSA-N Fc(cccc1)c1C(c1c2)=NCc3cnc[n]3-c1ccc2Cl Chemical compound Fc(cccc1)c1C(c1c2)=NCc3cnc[n]3-c1ccc2Cl SNNAXVYUFKNABL-UHFFFAOYSA-N 0.000 description 1
- QHSMEGADRFZVNE-UHFFFAOYSA-N OCc1ncc2[n]1-c(ccc(Cl)c1)c1C(c(cccc1)c1F)=NC2 Chemical compound OCc1ncc2[n]1-c(ccc(Cl)c1)c1C(c(cccc1)c1F)=NC2 QHSMEGADRFZVNE-UHFFFAOYSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- -1 benzodiazepine compound Chemical class 0.000 description 1
- 125000003310 benzodiazepinyl group Chemical group N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229950001490 climazolam Drugs 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210076814.4A CN103319486B (zh) | 2012-03-22 | 2012-03-22 | 合成4H‑咪唑并[1,5‑a][1,4]苯二氮卓,特别是咪达唑仑的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210076814.4A CN103319486B (zh) | 2012-03-22 | 2012-03-22 | 合成4H‑咪唑并[1,5‑a][1,4]苯二氮卓,特别是咪达唑仑的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103319486A CN103319486A (zh) | 2013-09-25 |
CN103319486B true CN103319486B (zh) | 2017-10-10 |
Family
ID=49188575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210076814.4A Expired - Fee Related CN103319486B (zh) | 2012-03-22 | 2012-03-22 | 合成4H‑咪唑并[1,5‑a][1,4]苯二氮卓,特别是咪达唑仑的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103319486B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106032380A (zh) * | 2015-03-16 | 2016-10-19 | 王志训 | 一种咪达唑仑的工业制造方法 |
CN106032381A (zh) * | 2015-03-16 | 2016-10-19 | 王志训 | 一种咪达唑仑衍生物的工业制造方法 |
WO2018035246A1 (en) | 2016-08-16 | 2018-02-22 | Uwm Research Foundation, Inc. | Gaba(a) receptor modulators and methods to control airway hyperresponsiveness and inflammation in asthma |
CN114685385A (zh) * | 2020-12-25 | 2022-07-01 | 成都苑东生物制药股份有限公司 | 一种咪达唑仑中间体的制备方法 |
CN115232132B (zh) * | 2022-07-25 | 2024-02-13 | 福安药业集团重庆礼邦药物开发有限公司 | 一种盐酸咪达唑仑g晶型及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102241679A (zh) * | 2010-05-04 | 2011-11-16 | 意大利合成制造有限公司 | 合成4H-咪唑并[1,5-a][1,4]苯二氮*、特别是咪达唑仑和其盐的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2159527A1 (de) * | 1970-12-11 | 1972-06-22 | Ciba-Geigy Ag, Basel (Schweiz) | Verfahren zur Herstellung von Diazepinderivaten und nach diesen Verfahren herstellbare neue Diazepinderivate |
US4280957A (en) * | 1974-09-11 | 1981-07-28 | Hoffmann-La Roche Inc. | Imidazodiazepines and processes therefor |
US20010014738A1 (en) * | 1999-06-30 | 2001-08-16 | Madhup K. Dhaon | Process for the preparation of imidazodiazepine intermediates |
-
2012
- 2012-03-22 CN CN201210076814.4A patent/CN103319486B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102241679A (zh) * | 2010-05-04 | 2011-11-16 | 意大利合成制造有限公司 | 合成4H-咪唑并[1,5-a][1,4]苯二氮*、特别是咪达唑仑和其盐的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103319486A (zh) | 2013-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103319486B (zh) | 合成4H‑咪唑并[1,5‑a][1,4]苯二氮卓,特别是咪达唑仑的方法 | |
CN106167449B (zh) | 一种对羟基苯乙酮的合成方法 | |
CN106892935A (zh) | 一种壳聚糖固载铜催化制备有机硼化合物的方法及应用 | |
CN114031542A (zh) | 一种氮杂双环医药中间体的制备新方法 | |
WO2012102247A1 (ja) | ルテニウム錯体を含む水素移動反応用触媒及び水素移動反応物の製造方法 | |
CN102140086A (zh) | 一种采用l-古龙酸合成维生素c粗品的方法 | |
CN106365986A (zh) | 化合物及其制备方法和在合成布瓦西坦中的用途 | |
CN103420979B (zh) | 埃索美拉唑钠的精制方法 | |
CN106905254B (zh) | 一种5-苯基-1h-四氮唑的制备方法 | |
CN103709086A (zh) | 依折麦布光学异构体的制备方法及该方法中使用的中间体 | |
CN102391128A (zh) | 一种抗生素医药中间体丙二酸单对硝基苄酯的生产方法 | |
CN107602399B (zh) | 一种脑啡肽酶抑制剂中间体的制备方法 | |
CN102199073A (zh) | 4,4'-二羟基二苯甲烷的制备方法 | |
CN104017042A (zh) | 一种7-去氢胆固醇的分离纯化方法 | |
CN101108824A (zh) | 用3-氰基吡啶合成2-氯-3-氰基吡啶的方法 | |
CN103980481B (zh) | 水溶性维生素e的制备方法 | |
CN103709039B (zh) | Cu-丝光沸石催化合成没食子酸甲(乙)酯的方法 | |
CN109134204B (zh) | 中间体2-溴-4-氟-5-氯苯酚的合成法 | |
CN107973715B (zh) | 一种多取代远端烯丙基酮衍生物的制备方法 | |
ES2875151T3 (es) | Procedimientos para la preparación de malonatos insaturados | |
CN104910033A (zh) | 一种制备5-氨基酮戊酸盐酸盐的方法 | |
CN104829571A (zh) | 草酸艾司西酞普兰相关物质及其制备方法 | |
CN110790708A (zh) | 一种艾利西平中间体的制备方法 | |
CN101987825A (zh) | 一种2-氨基-3-甲基-4-甲氧基苯乙酮的制备方法 | |
CN109400489B (zh) | 一种盐酸甲氯芬酯的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Gong Haibin Inventor after: Zhu Hailiang Inventor after: Hu Yang Inventor before: Zhu Hailiang Inventor before: Gong Haibin Inventor before: Hu Yang |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160918 Address after: 221009 Xuzhou Institute of cardiovascular diseases, 199 Jiefang South Road, Jiangsu, Xuzhou Applicant after: Xuzhou Cardiovascular Institute Applicant after: Nanjing University Address before: 210093 Nanjing, Gulou District, Jiangsu, No. 22 Hankou Road Applicant before: Nanjing University Applicant before: Xuzhou Cardiovascular Institute |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171010 Termination date: 20210322 |
|
CF01 | Termination of patent right due to non-payment of annual fee |